UMB Bank’s Regenxbio RGNX Stock Holding History

UMB Bank’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-153	Closed	-$1.6K	–	2164
2024 Q3	$1.6K	Buy	153 +76	+99%	+$926	﹤0.01%	2025
2024 Q2	$901	Buy	77 +61	+381%	+$949	﹤0.01%	1997
2024 Q1	$337	Buy	+16	New	+$285	﹤0.01%	2064

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UMB Bank's RGNX Position: Q4 2024 in Review

UMB Bank sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 153 shares — an estimated $1.6K sold.

UMB Bank first reported a position in RGNX in Q1 2024 and held it in 3 quarters. The position peaked at $1.6K in Q3 2024. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

UMB Bank reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
UMB Bank sold 153 Regenxbio shares in Q4 2024, an estimated $1.6K.
UMB Bank first reported a position in Regenxbio in Q1 2024 and held it in 3 quarters.
UMB Bank's Regenxbio position peaked at $1.6K in Q3 2024.
177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on UMB Bank's 13F filing for Q4 2024, filed 16 Jan 2025.